ImmuCell Corporation Other Accounts Payable and Accrued Liabilities
ImmuCell Corporation (ICCC) had Other Accounts Payable and Accrued Liabilities of $773.06 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2024-08-13
- 2024-06-30: Other Accounts Payable and Accrued Liabilities $773.06K.
- 2024-03-31: Other Accounts Payable and Accrued Liabilities $328.35K.
- 2023-12-31: Other Accounts Payable and Accrued Liabilities $192.75K.
- 2023-09-30: Other Accounts Payable and Accrued Liabilities $206.22K.
| Period end | Other Accounts Payable and Accrued Liabilities |
|---|---|
| 2024-06-30 | $773.06K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $328.35K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $192.75K 10-Q · filed 2024-08-13 |
| 2023-09-30 | $206.22K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $90.77K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $138.04K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $143.87K 10-K · filed 2024-04-01 |
| 2022-09-30 | $262.19K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $265.73K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $250.34K 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $199.08K 10-K · filed 2023-03-29 |
| 2021-09-30 | $197.14K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $192.59K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $141.87K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $137.48K 10-K · filed 2022-03-30 |
| 2020-09-30 | $230.10K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $221.75K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $388.22K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $175.11K 10-K · filed 2021-03-30 |
| 2019-09-30 | $135.69K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $136.92K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $190.23K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $165.42K 10-K · filed 2020-03-27 |
| 2018-09-30 | $116.86K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $113.44K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $185.90K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $182.48K 10-K · filed 2019-03-22 |
| 2017-09-30 | $255.77K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $148.65K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $164.96K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $101.53K 10-K · filed 2018-03-29 |
| 2016-09-30 | $28.97K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $208.15K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $252.54K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $93.98K 10-K · filed 2017-03-30 |
| 2015-09-30 | $71.06K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $36.16K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $57.39K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $76.11K 10-K · filed 2016-03-25 |
| 2013-12-31 | $96.21K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |